We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Vermillion Appoints Bruce A. Huebner as Interim CEO

News   Mar 25, 2013

 
Vermillion Appoints Bruce A. Huebner as Interim CEO
 
 
 

RELATED ARTICLES

AI Predicts Survival of Ovarian Cancer Patients

News

New machine learning software can forecast the survival rates and response to treatments of patients with ovarian cancer.

READ MORE

Blood Gene Expression Markers Predictive of Pain

News

A breakthrough test to measure pain in patients could help stem the tide of the opioid crisis in Indiana, and throughout the rest of the nation.

READ MORE

Fourth Gene Linked to Common Childhood Leukemia

News

Scientists have identified genetic variations in a fourth gene that are associated with an increased risk of acute lymphoblastic leukemia (ALL) in Hispanic children.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE